Kane Biotech (TSE:KNE) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Kane Biotech Inc. has achieved ISO 13485:2016 MDSAP Quality Certification, allowing it to seek regulatory approval for its medical products in Canada, Australia, New Zealand, and Brazil. This certification, which acknowledges Kane’s commitment to quality and patient safety, is a significant step for the company as it aims to improve the quality of chronic wound care products and expand its portfolio in these international markets.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.
